Objectives: a) Know currently available sources for information on psoriasis (most recent guidelines and reviews)
b) Know current treatment recommendations and underlying evidence on psoriasis
Introduction: Every year, new treatment options are available for the treatment of psoriasis. Keeping up with it all is a true challenge. Systematic reviews and guidelines can help for orientation and give guidance for specific clinical situations.
Materials / method: Extraction of key recommendations from current guidelines and systematic reviews.
Results: While topical treatments have seen little developments in the past, a total of 17 systemic treatments are licences in 2022 in Europe. Attempts to compare all treatments among other others by network metaanalysis show very good efficacy with regard to PASI 90 response for the newer treatment from the group of anti-Il23 and anti-Il 17 antibodies, with older treatments such as adalimumab and etanercept shower lower response rates.
Safety profiles and suitability in specific situations continue to shape with more experience with these drugs.
Conclusion: A trade-off between efficacy, safety and costs has to be consider to choose a treatment. Currently the more effective treatments tend to have a higher price in most countries.
Disclosures
Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): European Dermatology Forum
Were you provided with any honoraria, payment or other compensation for your work on this study?
No
Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No
Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No
This work is presented thanks to the support of: European Dermatology Forum